1. Inicio
  2. Proyectos y Estudios
  3. OBSERVATIONAL CROSS-SECTIONAL STUDY EVALUATING THE SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH METASTATIC MELANOMA HARBORING A BRAF V600 MUTATION, TREATED WITH COBIMETINIB AND VEMURAFENIB BASED ON ROUTINE CLINICAL PRACTICE.

OBSERVATIONAL CROSS-SECTIONAL STUDY EVALUATING THE SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH METASTATIC MELANOMA HARBORING A BRAF V600 MUTATION, TREATED WITH COBIMETINIB AND VEMURAFENIB BASED ON ROUTINE CLINICAL PRACTICE.

Datos básicos

ESTUDIO OBSERVACIONAL NACIONAL ROC-MMT-2017-01 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2018

Objetivos del proyecto

Observaciones: Estado Comité: ACTIVO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ROCHE FARMA, S.A.

Compartir